Trevor Marshall  from Murdoch University in Perth Australia.
Share

Contact me

Phone

(+1)8054923693

Email

trevor@trevormarshall.com

Fellow researchers

    Latest news

    • Research
    • School

    Dr Trevor Marshall
    BE, ME, PhD

    Adjunct Professor

    About me

    A 1974 graduate of the University of Adelaide, South Australia, Trevor Marshall was additionally awarded a Masters degree in 1978. In 1985 he graduated Ph.D. from the University of Western Australia, with the thesis topic: ‘Insulin metabolism in Diabetes.’ During the ‘1970s he had taught Engineering at the Institute of Technology in Lae, Papua New Guinea, and at W.A.I.T., now Curtin University, in Western Australia. He transitioned to Bioengineering in 1978, teaching at the University of Western Australia. In 1981 he was a visiting scientist at the Department of Surgery, Hospital for Sick Children, Toronto. He moved to California in 1982. He is currently Director of the Autoimmunity Research Foundation in Thousand Oaks, California and an adjunct professor in the Faculty of Health Sciences at Murdoch University, in Western Australia. He is currently best known for his discoveries in Translational Metagenomics and Autoimmune Disease. His treatment for chronic inflammatory diseases has became known as the Marshall Protocol (MP).  Collaborative research with Ted Keogh’s group at Sir Charles Gairdner in the 1980’s led to successful therapies for cryptorchidism, male and female infertility, and diabetes. He has won US FDA designations for minocycline and clindamycin in the treatment of sarcoidosis, and is currently steering the new drug product “Pure Olmesartan” through FDA review. Trevor has chaired sessions at international congresses on Autoimmunity, Genomics, and Neurology. Many of the conference presentations are archived at www.YouTube.com/DrTrevorMarshall . Trevor’s personal website is www.TrevorMarshall.com

    Teaching area

    Trevor’s teaching focus is on Predictive, Preventative and therapeutic modalities in Human Chronic Disease

    Research areas

    Trevor’s research focus is on Predictive, Preventative and therapeutic modalities in Human Chronic Disease

    Current projects

    Following publication of the metagenomic basis for the pathogenesis of Human Chronic Disease, Trevor is pursuing a number of projects, in conjunction with International collaborators, aimed at further elucidating Predictive, Preventative and Therapeutic options in Human Chronic Disease

    Events and speaking engagements

    Molecular Basis of Clinical Medicine, St Petersburg, Russia, 18-20 June 2012
    Plenary Presentation: The Microbiome which feeds the myriad of autoimmune diseases
    Video of Presentation: http://youtu.be/_rFmAMDdbjs
    PDF Transcript *available here*

    8th International Congress on Autoimmunity, Granada, 9-13 May 2012
    Plenary Presentation: What can Microbial Genomes tell us about Human Health
    Additional Presentation: The Human Microbiome lies at the Heart of Autoimmune Disease
    Video of Plenary Presentation: http://www.youtube.com/watch?v=g6sH7NTXkjw
    PDF Transcript *available here*

    5th Autoimmunity Congress Asia, Singapore, 17-19 Nov 2011
    Presentation: “How Microbes Cause Chronic Disease”
    Video of Presentation: http://Vimeo.com/32641708
    PDF Transcript *available here*

    EPMA – World Congress 2011, Bonn, Germany, 15-18 Sept 2011
    “Interplay between Microbiome and the Host’s Immunity as a Factor to be used for Prediction”

    NeuroTalk 2011, Dalian, China, May 2011
    Session Chair: Neurodegenerative Drug Discovery
    Presentation: “The Human Microbiome is the mechanism Fuelling Neurodegenerative Disorders”
    Video of presentation: from YouTube
    PDF Transcript *available here*

    2nd World DNA and Genome Day, Dalian, China, April 2011
    Session Chairman, Track 9: “Metagenomics”
    “The Human Microbiome lies at the Heart of Human Autoimmune Disease”
    Video of presentation: from YouTube

    Private Invitational summit on Multiple Sclerosis and Vit-D
    Glasgow, Scotland, Sept 21, 2010
    Video of presentation: from YouTube

    7th Intl. Congress on Autoimmunity, Ljubljana, Slovenia, May 2010
    Session Chair: Presentation: “The VDR Nuclear Receptor is Key to Reversing Autoimmune Disease.”
    Video of presentation: http://www.youtube.com/watch?v=z2yEwnZy8B8
    Or for China, on Vimeo: http://www.vimeo.com/user450718/videos

    4th Asian Congress on Autoimmunity, Singapore, 11-13 Sept 2009
    Session Co-Chairman: Autoimmunity and Etiology
    Presentation: “Autoimmune Diseases Succumb to a VDR Nuclear Receptor Agonist”
    Video of presentation: http://www.youtube.com/watch?v=hcAVeKobsxU

    4th Medical Biotech Forum, Dalian, China, 8-10 Aug 2009
    Presentation: “The VDR Nuclear Receptor is a Novel Proxy for MTSS1 and MTUS1 in Breast , Bladder and Colorectal Cancers”
    Video of presentation: http://vimeo.com/6110400
    Web transcript link: http://autoimmunityresearch.org/transcripts/CMBF_2009_Dalian_Transcript.pdf

    Workshop on Chlamydial Infection, Prague, Czech Republic, 18 Apr 2009
    Video of ‘Science’ presentation: http://vimeo.com/4307469
    Video of ‘Protocol’ presentation: http://www.vimeo.com/4293599
    Web transcript links: Science and Protocol

    2008 World Gene Congress, Foshan, China, 5-7 Dec 2008
    Keynote Speaker. Presentation video at http://www.vimeo.com/2585394

    6th Intl. Congress on Autoimmunity, Portugal, 10-14 Sept 2008
    co-Chair of session: ‘VDR and Vit D in Autoimmune Disease’, (Transcript here)
    Link to Video of Oral Presentation.

    Professional and community service

    Trevor has served as Director of the Autoimmunity Research Foundation since 2004

    Doctoral and masters supervisions

    Supervised PhD Candidate Amy Proal, Faculty of Health Sciences (graduated 2012)

    Publications

    Chapters

    • Proal, A., Albert, P., Marshall, T., (2011),Autoimmune Disease and the Human Metagenome,In: Metagenomics of the Human Body, Springer, pages 231 to 276.

    Journals

    • Proal, A., Albert, P., Marshall, T., Blaney, G., Lindseth, I., (2013), Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis, Immunologic Research, 56, 2-3, pages 398 - 412.
    • Proal, A., Albert, P., Blaney, G., Lindseth, I., Benediktsson, C., Marshall, T., (2011), Immunostimulation in the era of the metagenome, Cellular & Molecular Immunology, 8, 3, pages 213 - 225.
    • Albert, P., Proal, A., Marshall, T., (2009), Vitamin D: The alternative hypothesis, Autoimmunity Reviews, 8, 8, pages 639 - 644.
    • Proal, A., Albert, P., Marshall, T., (2009), Autoimmune disease in the era of the Metagenome, Autoimmunity Reviews, 8, 8, pages 677 - 681.
    • Proal, A., Albert, P., Marshall, T., (2009), Dysregulation of the Vitamin D NuclearReceptor may contribute to the higher prevalence of some autoimmune diseases in women, New York Academy of Sciences. Annals, 1173, , pages 252 - 259.
    • Marshall, T., (2008), Vitamin D discovery outpaces FDA decision making, BioEssays: advances in molecular, cellular and developmental biology, 2, 30, pages 173 - 182.

    Conference

    • Marshall, T., (2008),VDR Receptor Competence Induces Recovery from Chronic Autoimmune Disease,In: 6th International Congress on Autoimmunity (2008).